TD Securities Boosts WELL Health Technologies (TSE:WELL) Price Target to C$8.50

WELL Health Technologies (TSE:WELL) had its price target upped by TD Securities from C$8.00 to C$8.50 in a research note issued to investors on Tuesday morning,BayStreet.CA reports.

A number of other equities research analysts have also recently weighed in on WELL. Scotiabank upped their price target on WELL Health Technologies from C$6.00 to C$7.00 in a report on Monday. CIBC boosted their target price on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th. Haywood Securities raised their price target on WELL Health Technologies from C$8.00 to C$10.00 in a research report on Friday, December 13th. Finally, Ventum Financial cut their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

WELL Health Technologies Stock Performance

Shares of WELL stock opened at C$7.02 on Tuesday. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The stock has a 50 day simple moving average of C$5.35 and a 200-day simple moving average of C$4.78. The company has a market cap of C$1.75 billion, a price-to-earnings ratio of 12.32, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$7.19.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.